- Home
- DOCS vs RNR Comparison
DOCS vs RNR Comparison
Compare DOCS & RNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- RNR
- Stock Information
- Founded
- DOCS 2010
- RNR 1993
- Country
- DOCS United States
- RNR Bermuda
- Employees
- DOCS N/A
- RNR N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- RNR Property-Casualty Insurers
- Sector
- DOCS Technology
- RNR Finance
- Exchange
- DOCS Nasdaq
- RNR Nasdaq
- Market Cap
- DOCS 12.3B
- RNR 12.3B
- IPO Year
- DOCS 2021
- RNR 1995
- Fundamental
- Price
- DOCS $49.61
- RNR $264.68
- Analyst Decision
- DOCS Buy
- RNR Hold
- Analyst Count
- DOCS 20
- RNR 13
- Target Price
- DOCS $68.55
- RNR $290.82
- AVG Volume (30 Days)
- DOCS 1.8M
- RNR 476.0K
- Earning Date
- DOCS 11-06-2025
- RNR 10-28-2025
- Dividend Yield
- DOCS N/A
- RNR 0.61%
- EPS Growth
- DOCS 42.88
- RNR N/A
- EPS
- DOCS 1.25
- RNR 34.70
- Revenue
- DOCS $621,329,000.00
- RNR $12,214,870,000.00
- Revenue This Year
- DOCS $13.54
- RNR N/A
- Revenue Next Year
- DOCS $11.26
- RNR N/A
- P/E Ratio
- DOCS $39.74
- RNR $7.59
- Revenue Growth
- DOCS 20.21
- RNR N/A
- 52 Week Low
- DOCS $47.66
- RNR $219.00
- 52 Week High
- DOCS $85.21
- RNR $290.78
- Technical
- Relative Strength Index (RSI)
- DOCS 18.12
- RNR 58.73
- Support Level
- DOCS $65.22
- RNR $264.94
- Resistance Level
- DOCS $67.10
- RNR $269.82
- Average True Range (ATR)
- DOCS 2.19
- RNR 6.30
- MACD
- DOCS -1.60
- RNR 1.10
- Stochastic Oscillator
- DOCS 3.05
- RNR 77.33
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.